跳到主要內容

臺灣博碩士論文加值系統

(3.231.230.177) 您好!臺灣時間:2021/07/28 15:04
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:李鴻承
研究生(外文):Hung-cheng Li
論文名稱:轉錄抑制子Z40A/ZNF266作用的標靶基因鱗狀上皮細胞癌抗原辨認T細胞3(SART3)功能上之探討
論文名稱(外文):Functional study of transcription repressor Z40A/ZNF266 on the promoter of squamous cell carcinoma antigen recognized by T cells 3 (SART3)
指導教授:林文昌林文昌引用關係賴建勳賴建勳引用關係
指導教授(外文):Wen-chang LinJiann-Shiun Lai
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:醫學生物技術研究所
學門:醫藥衛生學門
學類:醫學技術及檢驗學類
論文種類:學術論文
論文出版年:2004
畢業學年度:92
語文別:中文
中文關鍵詞:鋅指
外文關鍵詞:Krüpple
相關次數:
  • 被引用被引用:0
  • 點閱點閱:111
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
Krüpple型鋅指 (zinc finger) 基因廣泛存在於不同生物體系中,推測人類基因組中有700個以上Krüpple型鋅指基因是目前所發現最大的蛋白質家族而大部分Krüpple家族基因的生物功能仍不是很清楚。已知功能的Krüpple型鋅指基因多與生長及發育有關。
Z40A/ZNF266為一個新型Krüpple型鋅指蛋白質。Z40A/ZNF266的開放讀碼區 (open reading frame) 是由6個外顯子 (exon) 所組成,含有616個胺基酸,主要包含Krüpple-associated box (KRAB) 區域和12個連續的C2H2型鋅指結構,分別位在N端及C端。Z40A/ZNF266廣泛表現在淋巴器官和非淋巴組織。Z40A/ZNF266表現在淋巴器官有脾臟、胸腺、周邊血液白血球和淋巴結;而Z40A/ZNF266表現在非淋巴組織則有睪丸、直腸、胃臟和甲狀腺。從生化功能上分析已知Z40A/ZNF266藉由KRAB區域進行轉錄抑制的功能;同時利用任意DNA結合位置篩選的方法確定Z40A/ZNF266 DNA結合位置的共通序列為5’GGCGATAAGTAA3’。
為更進一步地了解Z40A/ZNF266的生物功能,我們利用中研院生醫所常蘭陽博士實驗室設計的電腦程式搜尋Z40A/ZNF266的DNA結合序列存在於哪些標靶基因的啟動子,試圖了解Z40A/ZNF266調控生物功能的可能機制。本篇論文主要的工作是藉由Z40A/ZNF266 DNA結合位置的共通序列搜尋所得到其中一個Z40A/ZNF266的標靶基因,squamous cell carcinoma antigen recognized by T cells 3 (SART3),針對其做啟動子分析實驗 (promoter assay) 探討SART3啟動子的Z40A/ZNF266 DNA結合序列是否會受到外生性 (exogenous) 表現的Z40A/ZNF266所調控。並利用染色體免疫沈澱實驗 [chromatin immunoprecipitation (ChIP) assay] 分析Z40A/ZNF266結合在標靶基因的啟動子的可能性。並且利用RNA干擾實驗以siRNA knockdown內源性 (endogenous) Z40A/ZNF266基因的表現,觀察SART3標靶基因是否受到Z40A/ZNF266的調控。由啟動子分析實驗,外生性表現的Z40A/ZNF266在SART3啟動子有14%些微的轉錄抑制活性,但是為了避免受到內源性Z40A/ZNF266在此DNA結合序列的競爭,將外生性表現的Z40A/ZNF266融合VP16的轉錄活化區域 (activation domain),使得Z40A/ZNF266從轉錄抑制子變成轉錄活化子,此實驗結果發現報導基因 (reporter gene) 的轉錄活性有2倍的增加;同時在SART3啟動子不含Z40A/ZNF266 DNA結合序列時,發現所有的報導基因的轉錄活性都上升將近2倍,此結果發現Z40A/ZNF266能透過結合在SART3啟動子的Z40A/ZNF266 DNA結合位置抑制標靶基因SART3的表現。同時透過ChIP assay在體內 (in vivo) 情況下,發現Z40A/ZNF266和其輔助抑制子KRAB-associated protein-1形成複合體結合在標靶基因SART3啟動子上;除此之外,histone deacetylase-1、heterochromatin protein 1也發現會結合在SART3啟動子上,顯示SART3基因可能位在異染色質 (heterochromatin) 區域。最後以siRNA knockdown內源性Z40A/ZNF266的RNA表現,結果在siRNA knockdown內源性Z40A/ZNF266 48小時後當Z40A/ZNF266 RNA表現剩下9%的表現時,SART3的RNA表現卻只有些微上升17%,可能因為SART3啟動子只有一個Z40A/ZNF266 DNA結合位置,單獨排除內源性Z40A/ZNF266對於SART3基因的表現並沒有足夠的影響也有可能knockdown內源性Z40A/ZNF266後,其他含有KRAB區域的Krüpple型鋅指蛋白質可以結合在和Z40A/ZNF266相同的DNA結合位置持續調控SART3基因的表現,詳細可見討論。經由上述三項實驗結果發現Z40A/ZNF266可以透過SART3啟動子的Z40A/ZNF266 DNA結合位置調控SART3基因的表現。
Krüpple type zinc finger genes are widely present in different biology but their biological function is still unclear. At present, there are more than 700 Krüpple type zinc finger genes that involve in cell growth and differentiation in the human genome.
Z40A/ZNF266 is a novel Krüpple type zinc finger protein and its open reading frame contains six exons encoding 616 amino acids. Z40A/ZNF266 protein consists of two conserved domains: a Krüpple-associated box (KRAB) at the amino terminus and 12 consecutive C2H2 type zinc finger motifs at the carboxyl terminus. The Z40A/ZNF266 transcripts are broadly expressed among tissues, although it is not expressed ubiquitously. The transcripts not only predominantly expressed in lymphoid organs like spleen, thymus, peripheral blood leukocyte, and lymph node, but it also highly expresses in other nonlymphoid tissues, such as testis, colon, stomach, and thyroid. Through biochemical assays, the KRAB domain of Z40A/ZNF266 bears transcriptional repression activity. Using random DNA binding site selection method, we have identified that the DNA binding consensus sequence of Z40A/ZNF266 is 5’GGCGATAAGTAA3’.
To understand the biological function of Z40A/ZNF266, we have searched the putative target genes of Z40A/ZNF266 using computer program made by Dr. Ch’ang, L.-Y. lab. One of the candidates, squamous cell carcinoma antigen recognized by T cell 3 (SART3) contains the DNA binding consensus sequence of Z40A/ZNF266 at the promoter region upstream of 380 bps from its transcriptional starting site. By employing the promoter assay, chromatin immunoprecipitation (ChIP) assay, and siRNA knockdown experiment, we have found that: First, the transcriptional repression activity of luciferase reporter gene, which was driven by SART3 promoter, decreases about 14% when transient expression of Z40A/ZNF266 in the cells by promoter assay. To avoid endogenous Z40A/ZNF266 competing with exogenous Z40A/ZNF266 in the promoter assay, we then converted Z40A/ZNF266 to transcriptional activator fusion Z40A/ZNF266 with herpes viral protein VP16 activation domain. As a result, the reporter activity arises two folds, suggesting exogenous Z40A/ZNF266 binds to SART3 promoter in the cells. This result is further supported by the fact that the basal transcriptional activity of reporter gene without Z40A/ZNF266 binding site on the SART3 promoter is also about two folds higher than the activity of reporter gene with the Z40A/ZNF266 binding site on the SART3 promoter in the cells. Second, by using ChIP assay, the results show that Z40A/ZNF266 can be specifically crosslinked to the Z40A/ZNF266 DNA binding site on the endogenous SART3 promoter, so does KRAB-associated protein-1, the transcriptional corepressor of Z40A/ZNF266. Furthermore, the proteins involving in heterochromatin formation, such as histone deacetylase-1 and heterochromatin protein 1, are both bound to the promoter region of SART3 promoter, suggesting SART3 gene promoter associates with heterochromatin structure. Third, after 48 hours transiently transfection of small RNA duplexes of Z40A/ZNF266 to the cells, the expression of Z40A/ZNF266 transcript is significantly down to about 9% left; however, the expression of endogenous SART3 transcript only slightly increases 17% or so. It could be Z40A/ZNF266 is only one of the components on the complicate regulatory promoter of the SART3 gene. It might also be due to the redundancy activity of the zinc finger proteins on the SART3 promoter. There are several hypothses addressed in details in the chapter of Discuss. In conclusion, we have employed three different approaches to demonstrate that Z40A/ZNF266 binds to its binding site on the promoter of SART3 gene and it suggests that SART3 is the target gene of Z40A/ZNF266.
1. Abrink, M., J. A. Ortiz, C. Mark, C. Sanchez, C. Looman, L. Hellman, P. Chambon, and R. Losson. 2001. Conserved interaction between distinct Kruppel-associated box domains and the transcriptional intermediary factor 1 beta. Proc Natl Acad Sci U S A 98:1422-6.
2. Agami, R. 2002. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 6:829-34.
3. Agata, Y., E. Matsuda, and A. Shimizu. 1999. Two novel Kruppel-associated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1beta/KRIP-1). J Biol Chem 274:16412-22.
4. Ahringer, J. 2000. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet 16:351-6.
5. Ayer, D. E. 1999. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol 9:193-8.
6. Ayyanathan, K., M. S. Lechner, P. Bell, G. G. Maul, D. C. Schultz, Y. Yamada, K. Tanaka, K. Torigoe, and F. J. Rauscher, 3rd. 2003. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev 17:1855-69.
7. Baehr, W., and C. K. Chen. 2001. RP11 and RP13: unexpected gene loci. Trends Mol Med 7:484-6.
8. Bell, M., S. Schreiner, A. Damianov, R. Reddy, and A. Bindereif. 2002. p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor. Embo J 21:2724-35.
9. Bellefroid, E. J., D. A. Poncelet, P. J. Lecocq, O. Revelant, and J. A. Martial. 1991. The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc Natl Acad Sci U S A 88:3608-12.
10. Berg, J. M. 1992. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc Natl Acad Sci U S A 89:11109-10.
11. Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12:142-8.
12. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-9.
13. Borden, K. L. 2000. RING domains: master builders of molecular scaffolds? J Mol Biol 295:1103-12.
14. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-3.
15. Call, K. M., T. Glaser, C. Y. Ito, A. J. Buckler, J. Pelletier, D. A. Haber, E. A. Rose, A. Kral, H. Yeger, W. H. Lewis, and et al. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-20.
16. Chen, J., J. Lin, and A. J. Levine. 1995. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med 1:142-52.
17. Chicas, A., and G. Macino. 2001. Characteristics of post-transcriptional gene silencing. EMBO Rep 2:992-6.
18. Chowdhury, K., U. Deutsch, and P. Gruss. 1987. A multigene family encoding several "finger" structures is present and differentially active in mammalian genomes. Cell 48:771-8.
19. Courey, A. J., and S. Jia. 2001. Transcriptional repression: the long and the short of it. Genes Dev 15:2786-96.
20. Courey, A. J., and R. Tjian. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-98.
21. Cox, E. H., and G. L. McLendon. 2000. Zinc-dependent protein folding. Curr Opin Chem Biol 4:162-5.
22. Damianov, A., S. Schreiner, and A. Bindereif. 2004. Recycling of the U12-type spliceosome requires p110, a component of the U6atac snRNP. Mol Cell Biol 24:1700-8.
23. de Ruijter, A. J., A. H. van Gennip, H. N. Caron, S. Kemp, and A. B. van Kuilenburg. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737-49.
24. Dillon, N., and R. Festenstein. 2002. Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet 18:252-8.
25. Eissenberg, J. C., and S. C. Elgin. 2000. The HP1 protein family: getting a grip on chromatin. Curr Opin Genet Dev 10:204-10.
26. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-8.
27. Fahrner, J. A., and S. B. Baylin. 2003. Heterochromatin: stable and unstable invasions at home and abroad. Genes Dev 17:1805-12.
28. Falini, B., B. Bigerna, L. Pasqualucci, M. Fizzotti, M. F. Martelli, S. Pileri, A. Pinto, A. Carbone, S. Venturi, R. Pacini, G. Cattoretti, E. Pescarmona, F. Lo Coco, P. G. Pelicci, I. Anagnastopoulos, R. Dalla-Favera, and L. Flenghi. 1996. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 87:465-71.
29. Flaus, A., and T. Owen-Hughes. 2001. Mechanisms for ATP-dependent chromatin remodelling. Curr Opin Genet Dev 11:148-54.
30. Fuks, F., W. A. Burgers, N. Godin, M. Kasai, and T. Kouzarides. 2001. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. Embo J 20:2536-44.
31. Fukuda, K. 2001. Expression of the SART3 antigens in oral cancers. Kurume Med J 48:55-8.
32. Gilboa, E. 1999. The makings of a tumor rejection antigen. Immunity 11:263-70.
33. Grass, J. A., M. E. Boyer, S. Pal, J. Wu, M. J. Weiss, and E. H. Bresnick. 2003. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A 100:8811-6.
34. Haber, D. A., A. J. Buckler, T. Glaser, K. M. Call, J. Pelletier, R. L. Sohn, E. C. Douglass, and D. E. Housman. 1990. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-69.
35. Hanna-Rose, W., and U. Hansen. 1996. Active repression mechanisms of eukaryotic transcription repressors. Trends Genet 12:229-34.
36. Harada, K., A. Yamada, T. Mine, N. Kawagoe, H. Takasu, and K. Itoh. 2000. Mouse homologue of the human SART3 gene encoding tumor-rejection antigen. Jpn J Cancer Res 91:239-47.
37. Harada, K., A. Yamada, D. Yang, K. Itoh, and S. Shichijo. 2001. Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation. Int J Cancer 93:623-8.
38. Hengartner, C. J., V. E. Myer, S. M. Liao, C. J. Wilson, S. S. Koh, and R. A. Young. 1998. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell 2:43-53.
39. Hennemann, H., L. Vassen, C. Geisen, M. Eilers, and T. Moroy. 2003. Identification of a novel Kruppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activity. J Biol Chem 278:28799-811.
40. Inoue, H., H. Nojima, and H. Okayama. 1990. High efficiency transformation of Escherichia coli with plasmids. Gene 96:23-8.
41. Ito, M., S. Shichijo, Y. Miyagi, T. Kobayashi, N. Tsuda, A. Yamada, N. Saito, and K. Itoh. 2000. Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes. Int J Cancer 88:633-9.
42. Jacobson, S., and L. Pillus. 1999. Modifying chromatin and concepts of cancer. Curr Opin Genet Dev 9:175-84.
43. Jenkins, H. L., and C. A. Spencer. 2001. RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells. J Virol 75:9872-84.
44. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-80.
45. Jheon, A. H., B. Ganss, S. Cheifetz, and J. Sodek. 2001. Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J Biol Chem 276:18282-9.
46. Johnson, K. D., and E. H. Bresnick. 2002. Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods 26:27-36.
47. Jones, D. O., I. G. Cowell, and P. B. Singh. 2000. Mammalian chromodomain proteins: their role in genome organisation and expression. Bioessays 22:124-37.
48. Joseph, L. J., M. M. Le Beau, G. A. Jamieson, Jr., S. Acharya, T. B. Shows, J. D. Rowley, and V. P. Sukhatme. 1988. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci U S A 85:7164-8.
49. Kaczynski, J., T. Cook, and R. Urrutia. 2003. Sp1- and Kruppel-like transcription factors. Genome Biol 4:206.
50. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-90.
51. Kawagoe, N., I. Shintaku, S. Yutani, H. Etoh, K. Matuoka, S. Noda, and K. Itoh. 2000. Expression of the SART3 tumor rejection antigen in renal cell carcinoma. J Urol 164:2090-5.
52. Kawamoto, N., A. Yamada, S. Ohkouchi, T. Maeda, S. Tanaka, T. Hashimoto, Y. Saijo, S. Saijo, T. Nukiwa, S. Shichijo, H. Aizawa, and K. Itoh. 2003. IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients. Tissue Antigens 61:352-61.
53. Kim, S. S., Y. M. Chen, E. O'Leary, R. Witzgall, M. Vidal, and J. V. Bonventre. 1996. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A 93:15299-304.
54. Kinzler, K. W., J. M. Ruppert, S. H. Bigner, and B. Vogelstein. 1988. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 332:371-4.
55. Klug, A., and J. W. Schwabe. 1995. Protein motifs 5. Zinc fingers. Faseb J 9:597-604.
56. Laity, J. H., B. M. Lee, and P. E. Wright. 2001. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol 11:39-46.
57. Lee, M. S., G. P. Gippert, K. V. Soman, D. A. Case, and P. E. Wright. 1989. Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science 245:635-7.
58. Li, Z., D. Wang, X. Na, S. R. Schoen, E. M. Messing, and G. Wu. 2003. The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. Embo J 22:1857-67.
59. Liu, Y., B. O. Kim, C. Kao, C. Jung, J. T. Dalton, and J. J. He. 2004. Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation. J Biol Chem 279:21766-73.
60. Liu, Y., J. Li, B. O. Kim, B. S. Pace, and J. J. He. 2002. HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. J Biol Chem 277:23854-63.
61. Ma, J., K. K. Hwang, H. J. Worman, J. C. Courvalin, and J. C. Eissenberg. 2001. Expression and functional analysis of three isoforms of human heterochromatin-associated protein HP1 in Drosophila. Chromosoma 109:536-44.
62. Maldonado, E., M. Hampsey, and D. Reinberg. 1999. Repression: targeting the heart of the matter. Cell 99:455-8.
63. Mannervik, M., Y. Nibu, H. Zhang, and M. Levine. 1999. Transcriptional coregulators in development. Science 284:606-9.
64. Margolin, J. F., J. R. Friedman, W. K. Meyer, H. Vissing, H. J. Thiesen, and F. J. Rauscher, 3rd. 1994. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A 91:4509-13.
65. Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-63.
66. Milbrandt, J. 1987. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797-9.
67. Miller, J., A. D. McLachlan, and A. Klug. 1985. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. Embo J 4:1609-14.
68. Miyagi, Y., N. Imai, T. Sasatomi, A. Yamada, T. Mine, K. Katagiri, M. Nakagawa, A. Muto, S. Okouchi, H. Isomoto, K. Shirouzu, H. Yamana, and K. Itoh. 2001. Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides. Clin Cancer Res 7:3950-62.
69. Moosmann, P., O. Georgiev, B. Le Douarin, J. P. Bourquin, and W. Schaffner. 1996. Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res 24:4859-67.
70. Moosmann, P., O. Georgiev, H. J. Thiesen, M. Hagmann, and W. Schaffner. 1997. Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol Chem 378:669-77.
71. Murayama, K., T. Kobayashi, T. Imaizumi, K. Matsunaga, T. Kuramoto, M. Shigemori, S. Shichijo, and K. Itoh. 2000. Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides. J Immunother 23:511-8.
72. Nal, B., E. Mohr, and P. Ferrier. 2001. Location analysis of DNA-bound proteins at the whole-genome level: untangling transcriptional regulatory networks. Bioessays 23:473-6.
73. Ng, H. H., and A. Bird. 1999. DNA methylation and chromatin modification. Curr Opin Genet Dev 9:158-63.
74. Ng, H. H., and A. Bird. 2000. Histone deacetylases: silencers for hire. Trends Biochem Sci 25:121-6.
75. Nielsen, A. L., J. A. Ortiz, J. You, M. Oulad-Abdelghani, R. Khechumian, A. Gansmuller, P. Chambon, and R. Losson. 1999. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. Embo J 18:6385-95.
76. Niiya, F., S. Nishizaka, K. Matsunaga, K. Koufuji, M. Mori, H. Katai, H. Yamana, and K. Itoh. 2000. Expression of SART3 tumor-rejection antigen in gastric cancers. Jpn J Cancer Res 91:337-42.
77. Noguchi, M., K. Kobayashi, N. Suetsugu, K. Tomiyasu, S. Suekane, A. Yamada, K. Itoh, and S. Noda. 2003. Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination. Prostate 57:80-92.
78. O'Connor, M. J., S. H. Tan, C. H. Tan, and H. U. Bernard. 1996. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 70:6529-39.
79. Orlando, V. 2000. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99-104.
80. Parraga, G., S. J. Horvath, A. Eisen, W. E. Taylor, L. Hood, E. T. Young, and R. E. Klevit. 1988. Zinc-dependent structure of a single-finger domain of yeast ADR1. Science 241:1489-92.
81. Pavletich, N. P., and C. O. Pabo. 1991. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252:809-17.
82. Peng, H., G. E. Begg, S. L. Harper, J. R. Friedman, D. W. Speicher, and F. J. Rauscher, 3rd. 2000. Biochemical analysis of the Kruppel-associated box (KRAB) transcriptional repression domain. J Biol Chem 275:18000-10.
83. Peng, H., G. E. Begg, D. C. Schultz, J. R. Friedman, D. E. Jensen, D. W. Speicher, and F. J. Rauscher, 3rd. 2000. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J Mol Biol 295:1139-62.
84. Pengue, G., V. Calabro, P. C. Bartoli, A. Pagliuca, and L. Lania. 1994. Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res 22:2908-14.
85. Pickford, A. S., and C. Cogoni. 2003. RNA-mediated gene silencing. Cell Mol Life Sci 60:871-82.
86. Rader, S. D., and C. Guthrie. 2002. A conserved Lsm-interaction motif in Prp24 required for efficient U4/U6 di-snRNP formation. Rna 8:1378-92.
87. Redemann, N., U. Gaul, and H. Jackle. 1988. Disruption of a putative Cys-zinc interaction eliminates the biological activity of the Kruppel finger protein. Nature 332:90-2.
88. Ribas, A., L. H. Butterfield, J. A. Glaspy, and J. S. Economou. 2003. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 21:2415-32.
89. Ribas, A., J. M. Timmerman, L. H. Butterfield, and J. S. Economou. 2003. Determinant spreading and tumor responses after peptide-based cancer immunotherapy. Trends Immunol 24:58-61.
90. Richards, E. J., and S. C. Elgin. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489-500.
91. Robertson, K. D., S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25:338-42.
92. Rosati, M., M. Marino, A. Franze, A. Tramontano, and G. Grimaldi. 1991. Members of the zinc finger protein gene family sharing a conserved N-terminal module. Nucleic Acids Res 19:5661-7.
93. Ryan, R. F., D. C. Schultz, K. Ayyanathan, P. B. Singh, J. R. Friedman, W. J. Fredericks, and F. J. Rauscher, 3rd. 1999. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Biol 19:4366-78.
94. Saccani, S., S. Pantano, and G. Natoli. 2001. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193:1351-9.
95. Sasatomi, T., Y. Suefuji, K. Matsunaga, H. Yamana, Y. Miyagi, Y. Araki, Y. Ogata, K. Itoh, and K. Shirouzu. 2002. Expression of tumor rejection antigens in colorectal carcinomas. Cancer 94:1636-41.
96. Schlissel, M. S., and D. D. Brown. 1984. The transcriptional regulation of Xenopus 5s RNA genes in chromatin: the roles of active stable transcription complexes and histone H1. Cell 37:903-13.
97. Schmitz, M., M. Bornhauser, D. Ockert, and E. P. Rieber. 2002. Cancer immunotherapy: novel strategies and clinical experiences. Trends Immunol 23:428-9.
98. Schuh, R., W. Aicher, U. Gaul, S. Cote, A. Preiss, D. Maier, E. Seifert, U. Nauber, C. Schroder, R. Kemler, and et al. 1986. A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene. Cell 47:1025-32.
99. Schultz, D. C., J. R. Friedman, and F. J. Rauscher, 3rd. 2001. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev 15:428-43.
100. Segil, N., S. B. Roberts, and N. Heintz. 1991. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254:1814-6.
101. Stanek, D., S. D. Rader, M. Klingauf, and K. M. Neugebauer. 2003. Targeting of U4/U6 small nuclear RNP assembly factor SART3/p110 to Cajal bodies. J Cell Biol 160:505-16.
102. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606.
103. Suefuji, Y., T. Sasatomi, S. Shichijo, S. Nakagawa, H. Deguchi, T. Koga, T. Kameyama, and K. Itoh. 2001. Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients. Br J Cancer 84:915-9.
104. Suzuki, N., Y. Maeda, S. Tanaka, N. Hida, T. Mine, K. Yamamoto, M. Oka, and K. Itoh. 2002. Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer. Int J Cancer 98:45-50.
105. Tanaka, S., N. Tsuda, K. Kawano, M. Sakamoto, T. Nishida, T. Hashimoto, S. Shichijo, T. Kamura, and K. Itoh. 2000. Expression of tumor-rejection antigens in gynecologic cancers. Jpn J Cancer Res 91:1177-84.
106. Tricoli, J. V., and R. B. Bracken. 1993. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chromosomes Cancer 6:65-72.
107. Tsuda, N., K. Murayama, H. Ishida, K. Matsunaga, S. Komiya, K. Itoh, and A. Yamada. 2001. Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides. J Orthop Res 19:346-51.
108. Underhill, C., M. S. Qutob, S. P. Yee, and J. Torchia. 2000. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J Biol Chem 275:40463-70.
109. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-7.
110. Verheggen, C., G. Almouzni, and D. Hernandez-Verdun. 2000. The ribosomal RNA processing machinery is recruited to the nucleolar domain before RNA polymerase I during Xenopus laevis development. J Cell Biol 149:293-306.
111. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-35.
112. Vissing, H., W. K. Meyer, L. Aagaard, N. Tommerup, and H. J. Thiesen. 1995. Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins. FEBS Lett 369:153-7.
113. Weinmann, A. S., and P. J. Farnham. 2002. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26:37-47.
114. Wilkinson, D. G., S. Bhatt, P. Chavrier, R. Bravo, and P. Charnay. 1989. Segment-specific expression of a zinc-finger gene in the developing nervous system of the mouse. Nature 337:461-4.
115. Witzgall, R., E. O'Leary, A. Leaf, D. Onaldi, and J. V. Bonventre. 1994. The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci U S A 91:4514-8.
116. Wolfe, S. A., L. Nekludova, and C. O. Pabo. 2000. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct 29:183-212.
117. Yang, D., M. Nakao, S. Shichijo, T. Sasatomi, H. Takasu, H. Matsumoto, K. Mori, A. Hayashi, H. Yamana, K. Shirouzu, and K. Itoh. 1999. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res 59:4056-63.
118. Yun, J., and W. H. Lee. 2003. Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage. Mol Cell Biol 23:7305-14.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top